CCM Biosciences identifies novel enzyme activators with applications in longevity space

Founded by McGill Desautels Associate Professor Anisha Ghosh, with over $25 million in funding, CCM Biosciences is developing novel therapeutics in longevity. Recently, the company announced that it has developed an enzyme activator that can restore activity to youthful levels. This breakthrough has the potential to lead to drug development candidates for age-related disorders like Alzheimer’s and Parkinson’s Disease.